Evidence map›Paper›PMID 40476370›Full record

ArticleIUBMB life2025

Tyrosine and Phenylalanine Activate Neuronal DNA Repair but Exhibit Opposing Effects on Global Transcription and Adult Female Mice Are Resilient to TyrRS/YARS1 Depletion.

Megha Jhanji, Ashita Bhan, Colin Arrowood, Dina W Yakout, Ankit Shroff, Danielle McManus, Henrietta Gifford, Janay Vacharasin, Sofia B Lizarraga, Taras Y Nazarko and 2 more

Abstract read
In one paragraph

Article in IUBMB life, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Megha JhanjiDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
Ashita BhanDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
Colin ArrowoodDepartment of Biology, Georgia State University, Atlanta, Georgia, USA.
Dina W YakoutNeuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, Atlanta, Georgia, USA.
Ankit ShroffDepartment of Biology, Georgia State University, Atlanta, Georgia, USA.
Danielle McManusDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
Henrietta GiffordDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
Janay VacharasinDepartment of Biological Sciences, College of Arts and Sciences, University of South Carolina, Columbia, South Carolina, USA.
Sofia B LizarragaDepartment of Molecular Biology, Cell Biology, and Biochemistry, and Center for Translational Neuroscience, Brown University, Providence, Rhode Island, USA.
Taras Y NazarkoDepartment of Biology, Georgia State University, Atlanta, Georgia, USA.
Angela M MabbNeuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, Atlanta, Georgia, USA.
Mathew SajishDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.ORCID 0000-0001-6715-5953

Funding

Targeting NMDA Receptors and Brain Estradiol to Rescue Memory in Aging FemalesP20GM109091 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KIARIS, HIPPOKRATIS, RONINSON, IGOR B · 2014 to 2024
$25.2M
ASH1L mediated transcription networks in autism spectrum disordersR01MH127081 · NIMH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI Judy Shih-Hwa Liu, Sofia Beatriz Lizarraga · 2022 to 2026
$4.7M
Microscopy and Flow Cytometry CoreP30GM154632 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI Hippokratis Kiaris · 2024 to 2026
$4.5M
American Cancer Society (ACS)-Institutional Research IRG-17-179-04NIGMS NIH HHS P20 GM109091NIGMS NIH HHS P30 GM154632NIH HHS P20GM109091NIMH NIH HHS R01 MH127081
6 · The paper itself

Abstract

Serum tyrosine and phenylalanine levels increase during aging and age-associated disorders. We previously showed that tyrosyl-tRNA synthetase (TyrRS/YARS1) is reduced in Alzheimer's Disease (AD) brains, and tyrosine and phenylalanine decrease TyrRS in neurons. Here, we found that tau is a negative regulator, whereas estrogen and leucine act as positive regulators of TyrRS. Young female mice exhibit increased TyrRS in the cortex compared to male mice. Notably, young Tau knockout male, but not female mice showed increased cortical TyrRS. Tau accumulation in middle-aged female mice did not decrease cortical TyrRS compared to males, suggesting that middle-aged females are resilient to tau-mediated TyrRS depletion. Tyrosine and phenylalanine treatment decreased tubulin tyrosination, activated DNA repair pathways, and protected against etoposide (ETO) and camptothecin (CPT)-induced toxicity, respectively, in neurons. While tyrosine facilitated topoisomerase 1 (TOP1) recruitment to chromatin and inhibited global transcription, in contrast, phenylalanine recruited topoisomerase 2 beta (TOP2β) to chromatin and stimulated global transcription. Furthermore, tyrosine decreased the presence of DNA fragments in a comet assay whereas phenylalanine increased them. Addition of cis-resveratrol (cis-RSV) protected against tyrosine-induced transcription inhibition by facilitating the recruitment of both TOP1 and TOP2β to chromatin and increasing tubulin tyrosination. Moreover, cis-RSV decreased both total and phosphorylated tau and protected neurons against amyloid beta (Aβ)-induced neurite degeneration and DNA damage. Gene expression profiling using human embryonic stem cell (hESC)-derived neurons demonstrated that cis-RSV is a broad-spectrum neuroprotective and anti-viral agent. In contrast, trans-RSV mimics phenylalanine-induced gene expression, including downregulation of long genes and induction of an AD-like gene expression signature. This work suggests that age and disease-associated increases in serum tyrosine and phenylalanine levels would activate neuronal DNA repair while inhibiting transcription and tubulin tyrosination. cis-RSV protects against their toxicity by restoring tubulin tyrosination, TOP1 and TOP2β-mediated transcription, and decreasing tau in primary neurons.

Indexed as

Alzheimer DiseaseDNA RepairNeuronsPhenylalanineTyrosineTyrosine-tRNA LigaseAnimalsDNA Topoisomerases, Type IDNA Topoisomerases, Type IIFemaleHumansMaleMiceMice, Knockouttau ProteinsTranscription, GeneticDNA Topoisomerases, Type IDNA Topoisomerases, Type IIPhenylalaninetau ProteinsTyrosineTyrosine-tRNA Ligaseaminoacyl‐tRNA synthetasesamyloid betaaromatic amino acidsDNA repairfemale resilienceneuronal transcriptionresilience to tau accumulation

Identifiers

PMID40476370
PMCPMC12142579

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.